Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Revenues
Total revenues	$ 16,667,045	$ 8,653,289	$ 27,206,345	$ 13,467,033
Operating expenses
Cost of sales and supportive services	882,096	995,990	5,602,212	1,246,838
Selling, general and administrative	5,874,139	5,392,226	9,585,427	9,641,744
Research and development	6,840,099	2,263,971	10,386,876	4,566,756
Total operating expenses	13,596,334	8,652,187	25,574,515	15,455,338
Operating income/(loss)	3,070,711	1,102	1,631,830	(1,988,305)
Gain from change in fair value of warrant liability	49,559	442,269	400,663	1,361,070
Other income, net	72,373	24,235	95,694	49,803
Income/(loss) before income taxes	3,192,643	467,606	2,128,187	(577,432)
Provision for income taxes	(1,155,581)	(298,406)	(452,175)	(65,473)
Net and comprehensive income/(loss)	$ 2,037,062	$ 169,200	$ 1,676,012	$ (642,905)
Basic income/(loss) per share (in dollars per share)	$ 0.03	$ 0.00	$ 0.02	$ (0.01)
Diluted income/(loss) per share (in dollars per share)	$ 0.03	$ (0.00)	$ 0.02	$ (0.03)
Weighted average shares outstanding: basic (in shares)	72,678,333	75,810,641	72,873,366	76,281,211
Weighted average shares outstanding: diluted (in shares)	73,332,888	76,660,054	73,699,226	77,128,973
Product Sales and Supportive Services [Member]
Revenues
Total revenues	$ 8,615,765	$ 6,924,162	$ 15,936,637	$ 10,447,505
Research and Development [Member]
Revenues
Total revenues	$ 8,051,280	$ 1,729,127	$ 11,269,708	$ 3,019,528